Your browser doesn't support javascript.
loading
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
Fukuda, Naoki; Toda, Kazuhisa; Wang, Xiaofei; Ohmoto, Akihiro; Hayashi, Naomi; Urasaki, Tetsuya; Sato, Yasuyoshi; Nakano, Kenji; Ono, Makiko; Tomomatsu, Junichi; Mitani, Hiroki; Takahashi, Shunji.
Afiliación
  • Fukuda N; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Toda K; Department of Head and Neck Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Wang X; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ohmoto A; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hayashi N; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Urasaki T; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sato Y; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakano K; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ono M; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Tomomatsu J; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Mitani H; Department of Head and Neck Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan.
Endocr J ; 68(6): 639-647, 2021 Jun 28.
Article en En | MEDLINE | ID: mdl-33504716
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Neoplasias de la Tiroides / Adenocarcinoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr J Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Neoplasias de la Tiroides / Adenocarcinoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr J Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón